Gambling and betting

Medicines and impulse control: when new gambling calls for a treatment conversation

Someone may start treatment to feel steadier or ease symptoms, then notice something unexpected: urges to open a gambling game, spend more than usual, or continue an activity that is already causing harm. That deserves attention.

Article contents

Someone may start treatment to feel steadier or ease symptoms, then notice something unexpected: urges to open a gambling game, spend more than usual, or continue an activity that is already causing harm. That deserves attention. Taking a medicine does not automatically make someone addicted, and a new urge alone does not establish its cause. However, impulse-control problems have been described for certain specific medicines and should be discussed promptly with a clinician.

If unusual, difficult-to-resist urges develop during treatment, contact medical help now rather than leaving the question until the next routine appointment. Do not change treatment yourself to test a theory. Immediate danger to life, a risk of self-harm or violence calls for urgent local help or protection; notes can wait. Difficulty breathing, chest pain or seizures also require urgent medical help.

1. Notice a change without passing judgment on yourself

Imagine someone who used to follow sports results occasionally but now places bets more often and finds it difficult to stop. This is an illustrative situation, not a patient account or a diagnosis. What matters is the change relative to their own life: what is happening differently, which costs or relationships are affected, and when it was first noticed.

You can say, “It has become harder to stop, and I want to discuss whether treatment could be involved.” That leaves the question open. You need not first label yourself weak-willed, identify a culprit or prove that a tablet is the sole cause. A clinician needs useful facts; the person needs help with what is happening now.

Being employed, speaking clearly or working successfully does not remove the need to discuss an unusual urge. Equally, a purchase, an interest in gambling or a prescription does not establish addiction. Assessment concerns behavior, consequences and circumstances, rather than a person's moral worth.

2. A specific example: aripiprazole

In its December 2023 safety reminder, the UK regulator MHRA describes gambling and other impulse-control risks associated with aripiprazole. Reports concerned people both with and without previous gambling problems. Having no such history is therefore not a reason to dismiss a new change.

Aripiprazole is used to help manage particular mental health conditions. Its useful role and a possible adverse effect need to be considered together. The regulator asks prescribing clinicians to consider treatment changes and tells patients to discuss changes with a doctor. This is not an instruction for the reader to stop, reduce or replace the medicine themselves.

Reports of suspected reactions do not establish how often the effect occurs among everyone taking the drug: MHRA explicitly states this limitation. A report count is not a count of proven cases in the general population either. The warning does not establish that all antipsychotics act alike or that every prescription is a substance addiction.

3. Another example: ropinirole

The issue is not confined to medicines a person associates with psychiatry. The NHS describes ropinirole as a treatment for symptoms of Parkinson's disease and restless legs syndrome. Its side-effects page lists uncontrollable gambling, shopping or eating as reasons to contact medical help without delay.

This is an example involving a particular medicine, not a statement about every neurological prescription. A warning alone cannot calculate your personal likelihood, establish that the effect will certainly occur or transfer the frequency of other adverse effects to gambling urges.

The NHS separately warns against stopping ropinirole abruptly on your own. Treatment and possible changes are discussed with a doctor or specialist nurse. This article gives no withdrawal schedule. If danger arises, seek urgent medical assessment rather than waiting for a routine booking or experimenting with missed doses.

4. Timing raises an important question; it does not settle it

New behavior after starting or changing treatment is a reason to describe the sequence. “After” does not, by itself, explain the cause of every episode. Mention what else changed: how you feel, sleep, access to gambling, and other medicines or substances taken. There is no need to guess exact dates or hide earlier difficulties to make the account more convincing.

An adverse effect, physical adaptation to medicine, symptoms when treatment changes and addictive behavior are different questions. They do not become the same simply because a drug is involved. A medical conversation can help assess them in your circumstances. A safety warning alone also cannot establish a manufacturer's intent or promise legal compensation.

Do not investigate the suspected link through another bet or by stopping and restarting treatment yourself. Such a “test” adds risk and may disrupt useful care. A change already noticed is enough reason to ask for help; another loss is not required.

5. Four anchors for a message to your clinician

Prepare a brief account using what is already known, if useful. These original, optional anchors are not a medical scale or a condition of access:

  1. What changed: which new or stronger urge is hard to resist, and what harm is already apparent?
  2. What is known about timing: when was the change noticed relative to treatment, if you remember?
  3. What is being taken: names and prescription details available to you; unknowns can be clarified later.
  4. What is needed now: immediate safety, medical contact, protection of an essential expense or support from someone nearby?

Leave items blank or say “I don't know yet.” There is no need to upload prescriptions, statements, account numbers or passwords into an article. Share relevant treatment information with a particular professional through a suitable, secure channel. Immediate danger takes priority over completing the description.

6. Obtain a response about treatment

When contacting care, explain that a new or stronger, difficult-to-control urge has appeared during treatment, and describe the current consequences. The NHS aripiprazole page identifies such impulse-control difficulties as a reason for medical contact now. Communicating that at booking helps distinguish the issue from an ordinary administrative request.

If the prescriber is unavailable, seek an accessible local medical service that can assess urgency and help arrange the appropriate contact. Serious danger requires emergency help. Medication decisions belong in a medical assessment; this article does not prescribe stopping, substituting or continuing a dangerous situation until a routine visit.

SAMHSA suggests checking cost and possible waiting before arranging care. You can also ask about language and follow-up contact. US information cannot guarantee an appointment everywhere. A request or scheduled time does not mean an assessment has taken place. Ask where to turn if a response does not arrive or the situation worsens.

7. Address consequences at the same time

A treatment review does not automatically return lost money or restore trust in a single decision. While the medical question is being assessed, you can end the current gambling session without a last bet, protect essential expenses and seek suitable debt or gambling support.

The NHS describes help for gambling-related harm, including possible payment restrictions through a bank. That is an English context; check the options offered by your own bank and services where you live. An access barrier does not guarantee an outcome or replace medical assessment. No trial payment or new gambling platform is needed to test it.

Gambling support and debt advice can be sought alongside medical contact. None of those conversations requires first proving the final cause of the behavior. Borrowing to chase losses adds another uncertain decision to existing harm; work through financial obligations with suitable local help.

8. Involve others without secret control

MHRA also draws attention to changes noticed by family or friends. With an adult's consent, someone close can help describe observations, contact a service or stay nearby. They need not become the sole treatment coordinator and cannot guarantee that gambling will stop.

Discuss concrete matters: what help is wanted, what the helper can manage, and how essential expenses will remain available. Suspecting an adverse effect does not give someone the right to secretly change another adult's medicines, take passwords or freely control their money. The helper's own funds and safety matter too.

Children should not monitor an adult's medication, betting or mood. Threats and violence require protection regardless of their explanation or willingness to discuss treatment. Love, meaning in life and a supportive environment may help, but they are not conditions to perfect before accessing care. A sufficient next step is to report the change and seek available medical help while addressing immediate safety.

Sources and limits

  • MHRA, Aripiprazole: risk of pathological gambling — regulator safety reminder, 18 December 2023. Risk and suspected-reaction reports; neither a population incidence rate nor an individual treatment decision.
  • NHS, Side effects of aripiprazole — patient information, reviewed 6 April 2023. Urgency of medical contact; British service numbers and pathways have their local context.
  • NHS, Side effects of ropinirole — patient information, reviewed 1 April 2025. Specific adverse effects; frequencies of other events are not rates for gambling urges.
  • NHS, About ropinirole — information on use and the limits of stopping independently, reviewed 1 April 2025. Not a home plan for changing medication.
  • SAMHSA, How to Set Up an Appointment — 24 April 2023. First-contact arrangements in a US context; local availability must be checked.
  • NHS, Help for problems with gambling — reviewed 8 December 2023. Support and possible restrictions in an English context; no promise of international services or complete financial recovery.

Tags

impulse control, medicines, aripiprazole, ropinirole, gambling, adverse reactions, medical contact, treatment review, financial consequences, consent, family support, urgent safety

About the authors

Andrey Zarinsh is an author and founder of United Wisdom. He explores inner transformation, unity of traditions, intercultural dialogue and contemporary spiritual discipline. Instagram: @andrey.zarinsh.

Maria Evilkut is a co-author of United Wisdom. Alongside her research, she aims to test these ideas in practice and observe how principles of unity and mutual understanding work in real life between people and cultures. Instagram: @ilkutki.

Content review date: 14 October 2026. Language version: EN.